Stryker Corporation (SYK)
| Market Cap | 148.25B |
| Revenue (ttm) | 22.60B |
| Net Income (ttm) | 2.99B |
| Shares Out | 381.58M |
| EPS (ttm) | 7.76 |
| PE Ratio | 50.07 |
| Forward PE | 28.76 |
| Dividend | $3.36 (0.86%) |
| Ex-Dividend Date | Mar 31, 2025 |
| Volume | 596,069 |
| Open | 384.58 |
| Previous Close | 385.61 |
| Day's Range | 384.26 - 388.63 |
| 52-Week Range | 314.93 - 406.19 |
| Beta | 0.96 |
| Analysts | Buy |
| Price Target | 420.68 (+8.28%) |
| Earnings Date | Jan 28, 2025 |
About SYK
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,... [Read more]
Financial Performance
In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for SYK stock is "Buy." The 12-month stock price forecast is $420.68, which is an increase of 8.28% from the latest price.
News
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ:...
Kadant Set to Join S&P SmallCap 600
NEW YORK , Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE: KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 1...
Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day
Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headq...
Stryker announces Allan Golston will retire from Board of Directors
Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for ...
Sales Growth, Strategic Acquisitions Drive Stryker Higher
Medical device maker Stryker Corporation (SYK) benefits from more procedures, sales, and acquisitions.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
Stryker Corporation (NYSE:SYK) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neur...
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices
Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.
Overlooked Stock: SYK
Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry...
Stryker reports 2024 operating results and 2025 outlook
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024:
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Vi...
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decis...
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive wi...
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purc...
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medical, I...
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable January 31, 2025 to sharehold...
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Last year, Morgan Stanley upgraded its outlook for the U.S. MedTech sector to “Attractive,” believing the concerns around GLP-1s were already reflected in stock prices and that fundamentals were stron...
Stryker Bringing in Big Money
Strong financial performance has investors eyeing Stryker Corporation (SYK) closely.
Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination
FLOWER MOUND, Texas, USA, Nov. 19, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, unveiled the Oculan Lighting Platform, an innovative lighting solution designed to...
Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment
PORTAGE, Mich., USA, Nov. 14, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced its launch of the next generation of SurgiCount+ within its sponge management ...